Arrowhead Pharmaceuticals (ARWR) Net Equity Issued and Repurchased (2010 - 2026)
Arrowhead Pharmaceuticals' (ARWR) quarterly Net Equity Issued and Repurchased came in at -$44000.0 in Q1 2026, down 100.02% YoY from $241.4 million in Q1 2025, and down 100.09% on a QoQ basis from $48.2 million in Q4 2025.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals (ARWR) has 12 years of Net Equity Issued and Repurchased data on file, last reported at -$44000.0 in Q1 2026.
- Quarterly Net Equity Issued and Repurchased fell 100.02% year-over-year to -$44000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.2 million (down 80.05% YoY) and the FY2025 annual result came in at $241.4 million, down 43.77% from the prior year.
- Net Equity Issued and Repurchased declined to -$44000.0 in Q1 2026, from $48.2 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $241.4 million in Q1 2025 to a low of -$44000.0 in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Arrowhead Pharmaceuticals | 12.40 Bn | 10.80 Bn | - | 28.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.00 Mn |
| Mar 31, 2026 | 83.17 Mn |
| Dec 31, 2025 | 46.83 Mn |
| Mar 31, 2025 | 241.39 Mn |
| Mar 31, 2020 | -21,000.00 |
| Dec 31, 2019 | 250.50 Mn |
| Jun 30, 2019 | 60.52 Mn |
| Mar 31, 2019 | 60.52 Mn |
| Dec 31, 2018 | 60.52 Mn |
| Jun 30, 2017 | -272,818.00 |
| Mar 31, 2017 | 191,937.00 |
| Dec 31, 2016 | 12.50 Mn |
| Sep 30, 2016 | 21.50 Mn |
| Sep 30, 2014 | -49.00 |
| Jun 30, 2014 | 49.00 |
| Mar 31, 2014 | 109.82 Mn |
| Dec 31, 2013 | 62.82 Mn |
| Sep 30, 2013 | 2.00 |
| Mar 31, 2013 | 3.59 Mn |
| Dec 31, 2012 | 4.10 Mn |